Side-by-side · Research reference

DSIPvsPinealon

Side-by-side comparison across mechanism, dosage, evidence, side effects, administration, and stack synergies. Citations on every claim where available.

AHuman-MechanisticDraft8/36 cited

BHuman-MechanisticDraft12/36 cited

DSIP

Sleep modulator · Anti-stress

100–200 mcgPer doseSchneider 1986

HumanMechanisticSchneider 1986

HoursHalf-life (est)

SQ · Pre-sleep · Daily during cycle

Pinealon

Pineal-derived · Neuroprotective

5–10 mgPer cycle doseKhavinson 2014

HumanMechanisticKhavinson 2014

HoursHalf-life (est)

SQ or IM · Daily for 10 days · 1-2×/year

01Mechanism of Action

Parameter

DSIP

Pinealon

Primary target

Multiple — modulates HPA axis + thalamic delta-wave generation (proposed)Schneider 1986

Antioxidant defense + neuronal gene expression (proposed)Khavinson 2014

Pathway

Reduced cortisol/ACTH + enhanced delta-wave EEG activity → improved sleep onset + depthSchneider 1986

Modulation of antioxidant enzymes (SOD, catalase) + neurotrophic factor expressionKhavinson 2014

Downstream effect

Faster sleep onset, increased delta sleep, reduced stress response, possible anxiolytic effectSchneider 1986

Reduced oxidative stress in neurons; improved cognitive function in age-related declineKhavinson 2014

Feedback intact?

—

Origin

Endogenous peptide first isolated from rabbit blood during delta sleep; synthesised exogenouslySchneider 1986

Synthetic 4-AA peptide derived from pineal gland extractKhavinson 2014

Antibody development

—

02Dosage Protocols

Parameter

DSIP

Pinealon

Standard dose

100–200 mcg SQ pre-sleepSchneider 1986

5–10 mg / day for 10 daysKhavinson 2014

Frequency

Once daily, pre-sleep

Once daily during cycle

Lower / starter dose

50 mcg pre-sleep

2.5 mg / day

Evidence basis

Human-mechanistic + early clinicalSchneider 1986

Russian clinical trials + in vitroKhavinson 2014

Duration

8–12 weeks per cycle

10-day cycles, 1–2× per year

Reconstitution

Bacteriostatic water

Timing

30–60 min pre-sleep

No specific time

Half-life

Short plasma; CNS effects last hours

Hours

04Side Effects & Safety

Parameter

DSIP

Pinealon

Injection site reaction

Mild irritation

Drowsiness

Expected effect (intentional)

—

Vivid dreams

Anecdotally reported

—

Long-term safety

Limited modern RCT data

Limited Western data

Pregnancy / OB

Avoid

Absolute Contraindications

DSIP

·Pregnancy / breastfeeding
·Concurrent CNS-depressant therapy without supervision

Pinealon

·Pregnancy / breastfeeding

Relative Contraindications

DSIP

·Severe sleep apnoea (untreated)
·Concurrent benzodiazepine / opioid use

Pinealon

·Active malignancy (theoretical via gene expression modulation)

05Administration Protocol

Parameter

DSIP

Pinealon

1. Reconstitution

Add 1–2 mL bacteriostatic water to vial.

Add 1–2 mL bacteriostatic water to 10 mg vial.

2. Injection site

SQ — abdomen. Rotate sites.

SQ — abdomen preferred.

3. Timing

30–60 min pre-sleep.

Daily during cycle, any time.

4. Storage

Lyophilised: room temp. Reconstituted: refrigerate ≤30 days.

5. Needle

29–31G insulin syringe.

29–31G, 4–8 mm insulin syringe.

06Stack Synergy

DSIP

— no documented stacks

Pinealon

+ Epitalon

Moderate

View Epitalon →

Pinealon (neuroprotection) + Epitalon (telomerase activation) form the canonical Khavinson "longevity stack" — both pineal-derived bioregulators with complementary axes. Pinealon supports neuronal antioxidant defense; Epitalon supports telomere maintenance. Anecdotally cycled together 1–2× per year.

Pinealon: 5–10 mg SQ · daily × 10 days
Epitalon: 5–10 mg SQ · daily × 10 days (overlap or alternate)
Primary benefit: Neuroprotection + telomere preservation

Khavinson 2014 Khavinson 2003